Yüklüyor......

An amino-terminal BRAF deletion accounting for acquired resistance to RAF/EGFR inhibition in colorectal cancer

Although combination therapy with RAF and EGFR inhibitors has improved the survival outcomes of patients with BRAF-mutated colorectal cancer (CRC), acquired resistance invariably develops. The mechanisms of acquired resistance to RAF inhibitors have been largely attributed to activating mutations in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cold Spring Harb Mol Case Stud
Asıl Yazarlar: Tung, Jack K., Neishaboori, Nastaran, Haraldsdottir, Sigurdis, Suarez, Carlos J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cold Spring Harbor Laboratory Press 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7476412/
https://ncbi.nlm.nih.gov/pubmed/32669268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/mcs.a005140
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!